PRESS RELEASE
News
-
-
PRESS RELEASE
Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease
Sanofi's venglustat receives Breakthrough Therapy designation in the US for type 3 Gaucher disease, a rare lysosomal storage disorder. Positive results from the LEAP2MONO study show significant improvements in neurological symptoms -
-
-
-
-
PRESS RELEASE
Communiqué de presse : Le Conseil d’administration de Sanofi propose la nomination de Christel Heydemann en qualité d’administratrice indépendante
Le Conseil d'administration de Sanofi propose la nomination de Christel Heydemann en tant qu'administratrice indépendante lors de l'Assemblée générale des actionnaires. Restructuration de la gouvernance chez Sanofi -
PRESS RELEASE
Press Release: Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director
Sanofi's Board of Directors proposes appointment of Christel Heydemann as independent director, renewing mandates, and thanking Patrick Kron. Heydemann brings expertise in industrial and digital transformation, strengthening governance diversity -
-
